T HE development of the Cavitron ultrasonic surgical aspirator (CUSA),* allowing tissue dissection by fragmentation, has provided a means of enhancing the safety of removing central and peripheral nervous system tumors. 1.2.5 However, the consequences of CUSA removal on the viability necessary to allow the in vitro and in vivo growth, establishment in culture, and analysis of tumor cells removed with this technique are unclear. Previous reports have suggested that tumor cells collected in the irrigation fluid of the CUSA are viable and demonstrate short-term growth in cell culture; furthermore, Lewis lung carcinoma tumor cells obtained by CUSA were tumorigenic in C57B 1 / 10 mice.9'1~ Nevertheless, successful sustained growth and analysis of CUSA-obtained human braintumor samples have not been reported and the concern is raised that comprehensive study of these tumors may be adversely affected by use of this technique.
We now report simple modifications of the CUSA and handling of aspirated tumor allowing sterile collection of concentrated human medulloblastoma fragments. The subsequent growth and analysis of these * Cavitron ultrasonic surgical aspirator supplied by Cooper Medical, Stanford, Connecticut. fragments in long-term cell culture and transplantation of xenografts in athymic nude mice are described.
Materials and Methods

Tumor Collection
The sterile collection of tumor fragments was facilitated by interruption of the suction line of a CUSA with a sterile trap, most efficiently accomplished with a sputum collector. Following collection of the fragments, the trap was sealed, placed on ice, and immediately transported to the laboratory. This technique was carried out in four children with posterior fossa tumors while undergoing craniotomy and gross total resection of a medulloblastoma using a CUSA equipped with a sterile trap.
Tumor Fragment Handling
The bloody irrigation fluid containing the tumor fragments was centrifuged at 1000 rpm for 5 minutes, the contaminating red blood cells in the pellet were lysed with 0.83% ammonium chloride (0*C), and the centrifugation/lysis procedure was repeated until a pellet virtually free of red blood cells was obtained. The tissue fragments were mechanically disaggregated into a single cell suspension for initiation into cell culture and inoculation into athymic nude mice as previously described. 8
Cell Culture
Cells were cultured in 100-mm Petri dishes and suspension flasks and were incubated at 37~ in a 5% CO#95% air atmosphere. Adherent cell cultures were fed when the pH of the medium dropped and were subcultured at confluence by exposure to 0.12% trypsin and 0.02% ethylenediaminetetra-acetic acid. Suspension cultures were similarly fed and subcultured twice weekly. Nonviable cells were removed by Ficoll-Hypaque density gradient centrifugation.t
Xenografi Transplantation
Male or female BALB/c mice (nu/nu genotype), 3 to 4 weeks of age, were inoculated with tumor. Their breeding and husbandry was performed as described previously. 4 Subcutaneous and intracranial xenografts resulting from initial tumor inoculation into these sites in athymic mice were serially transplanted as described previously# Chromosomal analysis of the in vitro cell lines and the xenografts were all performed as previously described. 6"8
Results
Cell Culture
The initiation into cell culture of the four tumors has resulted in the generation of four human medulloblastoma cell lines: D384 Med, D407 Med, D412 Med, and D425 Med. Although D407 Med and D412 Med have not been in culture long enough (> 70 passages) to be termed continuous, D384 Med and D425 Med (100 and 75 passage levels, respectively) represent the fourth and fifth human medulloblastoma cell lines established as continuous lines. Characterization of these continuous cell lines is currently in progress, allowing definition of their phenotypic and genotypic characteristics (and determining if the drug resistance seen in the primary tumors is present in the cell lines).
Xenografis
Inoculation of athymic nude mice with the cell suspension derived from the primary tumor has resulted in xenograft formation in D384 Med, D407 Med, and D425 Med. The latency of xenograft formation following initial tumor inoculation was variable (l to 6 months), suggesting that D412 Med (presently only 5 months since inoculation) may still demonstrate xenograft formation in the host animals. The D384 Med and D425 Med tumors have been serially passaged at both intracranial and subcutaneous sites for 10 generations, establishing conclusively that they are serially transplantable xenografis derived from human met Ficoll-Hypaque density gradient centrifugation supplied by LSM, Organon Teknika Co., Durham, North Carolina. dulloblastoma. The D384 Med, D407 Med, and D425 Med tumors grew as highly cellular and invasive neoplasms, largely located within the subarachnoid space; D384 Med and D425 Med grew subcutaneously as highly cellular and invasive undifferentiated tumors.
Chromosomal Analysis
Chromosomal analysis, to be reported separately in detail, confirmed the human origin of the cell lines in vitro and of the xenografts in vivo. Furthermore, D384 Med and D425 Med demonstrated double minutes in both the cell lines and xenografts.
Discussion
The development of the CUSA has greatly facilitated neurosurgical intervention for removal of central or peripheral nervous system tumors adjacent to or within vital structures. However, laboratory studies defining the phenotypic and genotypic properties of these tumors, both in cell culture and as xenografts in immunoincompetent animals, require viable tumor fragments free of microbial or red blood cell contamination. Our laboratory has successfully established both human glioma and meduUoblastoma continuous cell lines and transplantable xenografts derived from large tumor fragments taken from operative material in the routine manner. 3-7"8 Cell lines and transplantable xenografts initiated with CUSA-derived human tumor fragments have not been previously reported. Successful use of these fragments requires sterile collection of viable tumor cells with atraumatic removal of the blood characteristically present in the CUSA aspirate.
Our use of a readily available sterile sputum trap, coupled with serial centrifugation and ammonium chloride-mediated lysis of contaminating red blood cells, provided a concentrated source of viable tumor cells, facilitating initiation into cell lines and inoculation into athymic mice. Studies in progress with these new cell lines and xenografts, particularly with D384 Med and D425 Med, are continuing in order to define the biology and therapeutic profile of medulloblastoma. Application of the technique reported here may allow laboratory growth and analysis of central and peripheral nervous system tumors resected by the CUSA and is particularly adaptable to many of the less frequently occurring childhood brain tumors, for which there is a great paucity of established lines. Furthermore, use of this approach to collect viable tissue for subsequent transplantation (such as into patients with Parkinson's disease) may bear investigation.
